MedTech Solutions, a manufacturer of implantable cardiac pacemakers, has recently launched a new model onto the market. After six months of sales, the company\'s post-market surveillance team begins to receive an increasing number of reports from hospitals indicating a higher-than-expected rate of battery depletion in the pacemakers, leading to premature device replacements. The reports include detailed patient information, device serial numbers, and specific measurements of battery voltage over time. According to ISO 13485:2016 requirements for risk management and post-market surveillance, what is the MOST appropriate initial action for MedTech Solutions to take upon receiving this trend of concerning post-market data? The data includes customer feedback, audit results, and process performance. This action should align with maintaining compliance and ensuring patient safety while adhering to the standard\'s focus on continuous improvement and risk mitigation.